The data for autism looks pretty robust which is their primary focus.
Other research teams using their IP is a case of heads we win , tails we don’t lose much ( would imagine little cost to BlinkLab for this research)
- Forums
- ASX - By Stock
- BB1
- Ann: BlinkLab starts Clinical Study with Bates College
Ann: BlinkLab starts Clinical Study with Bates College, page-3
Featured News
Add BB1 (ASX) to my watchlist
(20min delay)
|
|||||
Last
26.8¢ |
Change
0.023(9.18%) |
Mkt cap ! $15.27M |
Open | High | Low | Value | Volume |
24.5¢ | 27.0¢ | 24.5¢ | $267.3K | 1.080M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 61605 | 26.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
27.0¢ | 1075 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 61605 | 0.265 |
2 | 91000 | 0.260 |
1 | 24774 | 0.255 |
2 | 210005 | 0.250 |
2 | 12528 | 0.245 |
Price($) | Vol. | No. |
---|---|---|
0.270 | 1075 | 1 |
0.280 | 50000 | 1 |
0.285 | 10000 | 1 |
0.290 | 100000 | 1 |
0.310 | 59750 | 1 |
Last trade - 14.32pm 08/11/2024 (20 minute delay) ? |
Featured News
BB1 (ASX) Chart |
The Watchlist
EQN
EQUINOX RESOURCES LIMITED.
Zac Komur, MD & CEO
Zac Komur
MD & CEO
SPONSORED BY The Market Online